CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,929,000 | +65.6% | 884,969 | +4.0% | 1.29% | +47.5% |
Q2 2022 | $3,581,000 | +296.6% | 850,647 | +2337.0% | 0.87% | +439.5% |
Q4 2017 | $903,000 | -45.1% | 34,905 | -71.0% | 0.16% | -37.0% |
Q1 2016 | $1,645,000 | -35.0% | 120,423 | -9.7% | 0.26% | -22.4% |
Q4 2015 | $2,529,000 | +0.5% | 133,317 | -0.6% | 0.33% | -17.0% |
Q3 2015 | $2,517,000 | +105.3% | 134,121 | +62.9% | 0.40% | +179.0% |
Q2 2015 | $1,226,000 | -1.8% | 82,319 | -0.1% | 0.14% | -0.7% |
Q1 2015 | $1,248,000 | -67.4% | 82,434 | -72.8% | 0.14% | -81.5% |
Q3 2014 | $3,823,000 | – | 303,142 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |